Compare Plby Group Inc (PLBY) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Plby Group Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Plby Group Inc trades at $1.28 (market cap $143.34M), while Regeneron Pharmaceuticals Inc trades at $653.5 (market cap $70.79B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 493.9× Plby Group Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Plby Group Inc pays none. Which is the better fit depends on your goals.
| PLBY | REGN | |
|---|---|---|
Market Cap | $143.34M | $70.79B |
Sector | Consumer Cyclical | Health |
52-Week High | $2.71 | $812.27 |
52-Week Low | $1.11 | $545.46 |
Enterprise Value | $291.14M | $64.74B |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Plby Group Inc
PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.
Read more on PLBY →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
